On today’s episode of AD Nauseam, Amy, Daniel, and their special guest Randy Shaheen, another partner in BakerHostetler’s Advertising Marketing, and Digital Media team, will continue their deep dive into the FTC’s recent Health Products Compliance Guidance document. This is the second in a three-part series, and today they will provide 1) an overview of the science underlying much of the new Guidance 2) a focus on red flags to avoid and 3) a discussion of some of the FTC cases that highlight the science.

Questions & Comments: dkaufman@bakerlaw.com;  amudge@bakerlaw.com; and rshaheen@bakerlaw.com